Cargando…

Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease

IMPORTANCE: Monogenic familial hypercholesterolemia (FH) is associated with lifelong elevations in low-density lipoprotein cholesterol (LDL-C) levels and increased risk of atherosclerotic cardiovascular disease (CVD). However, many individuals with hypercholesterolemia have a polygenic rather than a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trinder, Mark, Francis, Gordon A., Brunham, Liam R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042820/ https://www.ncbi.nlm.nih.gov/pubmed/32049305 http://dx.doi.org/10.1001/jamacardio.2019.5954

Ejemplares similares

Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial Hypercholesterolemia
por: Trinder, Mark, et al.
Publicado: (2020)

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Lee, Timothy, et al.
Publicado: (2019)

Greater preclinical atherosclerosis in treated monogenic familial hypercholesterolemia vs. polygenic hypercholesterolemia
por: Sharifi, Mahtab, et al.
Publicado: (2017)

The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022)

Polygenic Hypercholesterolemia and Cardiovascular Disease Risk
por: Sharifi, Mahtab, et al.
Publicado: (2019)

Patient Perspectives Regarding Genetic Testing for Familial Hypercholesterolemia
por: Marchand, Miles, et al.
Publicado: (2021)

Clinical Utility of Lipoprotein(a) and LPA Genetic Risk Score in Risk Prediction of Incident Atherosclerotic Cardiovascular Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
por: Mickiewicz, Agnieszka, et al.
Publicado: (2020)

Sex Differences in the Presentation, Treatment, and Outcome of Patients With Familial Hypercholesterolemia
por: Ryzhaya, Natalia, et al.
Publicado: (2021)

Clinical Implications of Monogenic Versus Polygenic Hypercholesterolemia: Long‐Term Response to Treatment, Coronary Atherosclerosis Burden, and Cardiovascular Events
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Polygenic risk affects the penetrance of monogenic kidney disease
por: Khan, Atlas, et al.
Publicado: (2023)

The Polygenic and Monogenic Basis of Blood Traits and Diseases
por: Vuckovic, Dragana, et al.
Publicado: (2020)

The Polygenic and Monogenic Basis of Paediatric Fractures
por: Ghatan, S., et al.
Publicado: (2021)

Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease in the Asia-Pacific Region
por: Tada, Hayato, et al.
Publicado: (2021)

Polygenic risk score for hypercholesterolemia in a Brazilian familial hypercholesterolemia cohort
por: Lima, Isabella Ramos, et al.
Publicado: (2022)

From monogenic to polygenic obesity: recent advances
por: Hinney, Anke, et al.
Publicado: (2010)

Clinical Implementation of Combined Monogenic and Polygenic Risk Disclosure for Coronary Artery Disease
por: Maamari, Dimitri J., et al.
Publicado: (2022)

Familial Hypercholesterolemia and the Atherosclerotic Disease
por: Kim, Yoo Ri, et al.
Publicado: (2013)

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
por: Khera, Amit V., et al.
Publicado: (2018)

Premature Atherosclerotic Cardiovascular Disease: Trends in Incidence, Risk Factors, and Sex‐Related Differences, 2000 to 2016
por: Vikulova, Diana N., et al.
Publicado: (2019)

Monogenic and polygenic inheritance become instruments for clonal selection
por: Loh, Po-Ru, et al.
Publicado: (2020)

Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases
por: Clarke, Thomas, et al.
Publicado: (2023)

Association between Achilles Tendon Softness and Atherosclerotic Cardiovascular Disease in Patients with Familial Hypercholesterolemia
por: Michikura, Masahito, et al.
Publicado: (2022)

Variation and impact of polygenic hematologic traits in monogenic sickle cell disease
por: Pincez, Thomas, et al.
Publicado: (2022)

Prevalence of Diabetes and Its Association with Atherosclerotic Cardiovascular Disease Risk in Patients with Familial Hypercholesterolemia: An Analysis from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)
por: Boutari, Chrysoula, et al.
Publicado: (2022)

Genetics of Smoking and Risk of Atherosclerotic Cardiovascular Diseases: A Mendelian Randomization Study
por: Levin, Michael G., et al.
Publicado: (2021)

Update on Genetic Basis of Brugada Syndrome: Monogenic, Polygenic or Oligogenic?
por: Campuzano, Oscar, et al.
Publicado: (2020)

A polygenic biomarker to identify patients with severe hypercholesterolemia of polygenic origin
por: Leal, Luis G., et al.
Publicado: (2020)

Association of triglyceride-glucose index with atherosclerotic cardiovascular disease and mortality among familial hypercholesterolemia patients
por: Wen, Jun, et al.
Publicado: (2023)

Association Between Polygenic Risk Score and Risk of Myopia
por: Ghorbani Mojarrad, Neema, et al.
Publicado: (2019)

Association of Vascular Risk Factors and Genetic Factors With Penetrance of Variants Causing Monogenic Stroke
por: Cho, Bernard P. H., et al.
Publicado: (2022)

Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases
por: Deo, Salil V., et al.
Publicado: (2023)

Large-Scale Screening for Monogenic and Clinically Defined Familial Hypercholesterolemia in Iceland
por: Björnsson, Eythór, et al.
Publicado: (2021)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Impact of the severe familial hypercholesterolemia status on atherosclerotic risks
por: Tada, Hayato, et al.
Publicado: (2023)

Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis
por: Sturm, Amy C., et al.
Publicado: (2021)

Assessment of subclinical atherosclerotic cardiovascular disease in patients with ankylosing spondylitis
por: Hatipsoylu, Erdinç, et al.
Publicado: (2019)

Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System
por: Vassy, Jason L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_utib4gcsec35u96eaka69l4eg9